These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 11320389)

  • 1. Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.
    Espinal MA; Laszlo A; Simonsen L; Boulahbal F; Kim SJ; Reniero A; Hoffner S; Rieder HL; Binkin N; Dye C; Williams R; Raviglione MC
    N Engl J Med; 2001 Apr; 344(17):1294-303. PubMed ID: 11320389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.
    Pablos-Méndez A; Raviglione MC; Laszlo A; Binkin N; Rieder HL; Bustreo F; Cohn DL; Lambregts-van Weezenbeek CS; Kim SJ; Chaulet P; Nunn P
    N Engl J Med; 1998 Jun; 338(23):1641-9. PubMed ID: 9614254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis.
    Aziz MA; Wright A; Laszlo A; De Muynck A; Portaels F; Van Deun A; Wells C; Nunn P; Blanc L; Raviglione M;
    Lancet; 2006 Dec; 368(9553):2142-54. PubMed ID: 17174706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of primary and acquired resistance of Mycobacterium tuberculosis to antituberculosis drugs in Benin after 12 years of short-course chemotherapy.
    Trébucq A; Anagonou S; Gninafon M; Lambregts K; Boulahbal F
    Int J Tuberc Lung Dis; 1999 Jun; 3(6):466-70. PubMed ID: 10383057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Surveillance of Mycobacterium tuberculosis resistance to antituberculosis drugs].
    Garzón MC; Angée DY; Llerena C; Orjuela DL; Victoria JE
    Biomedica; 2008 Sep; 28(3):319-26. PubMed ID: 19034356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardization of antituberculosis drug resistance surveillance in Europe. Recommendations of a World Health Organization (WHO) and International Union Against Tuberculosis and Lung Disease (IUATLD) Working Group.
    Schwoebel V; Lambregts-van Weezenbeek CS; Moro ML; Drobniewski F; Hoffner SE; Raviglione MC; Rieder HL
    Eur Respir J; 2000 Aug; 16(2):364-71. PubMed ID: 10968516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance.
    Wright A; Zignol M; Van Deun A; Falzon D; Gerdes SR; Feldman K; Hoffner S; Drobniewski F; Barrera L; van Soolingen D; Boulabhal F; Paramasivan CN; Kam KM; Mitarai S; Nunn P; Raviglione M;
    Lancet; 2009 May; 373(9678):1861-73. PubMed ID: 19375159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
    Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The World Health Organization/International Union Against Tuberculosis and Lung Disease Global Project on Surveillance for Anti-Tuberculosis Drug Resistance: a model for other infectious diseases.
    Aziz MA; Wright A
    Clin Infect Dis; 2005 Aug; 41 Suppl 4():S258-62. PubMed ID: 16032561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-tuberculosis drug resistance in Japan and in the world].
    Abe C
    Kekkaku; 2001 Nov; 76(11):699-706. PubMed ID: 11766361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-resistant tuberculosis in the Dominican Republic: results of a nationwide survey.
    Espinal MA; Báez J; Soriano G; Garcia V; Laszlo A; Reingold AL; Sanchez S
    Int J Tuberc Lung Dis; 1998 Jun; 2(6):490-8. PubMed ID: 9626607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Surveillance of resistance of Mycobacterium tuberculosis to anti-TB drugs in Cuba, 1995-1998].
    Montoro E; Echemendía M; Lemus D; Marrero A; Llanes MJ; Valdivia JA
    Biomedica; 2004 Jun; 24 Supp 1():80-4. PubMed ID: 15495575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in drug-resistant Mycobacterium tuberculosis in New York City, 1991-2003.
    Munsiff SS; Li J; Cook SV; Piatek A; Laraque F; Ebrahimzadeh A; Fujiwara PI
    Clin Infect Dis; 2006 Jun; 42(12):1702-10. PubMed ID: 16705575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug resistance pulmonary tuberculosis in the Eastern Province of Saudi Arabia.
    Al-Rubaish AM; Madania AA; Al-Muhanna FA
    Saudi Med J; 2001 Sep; 22(9):776-9. PubMed ID: 11590451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-resistant tuberculosis in Taipei, 1996-1999.
    Wang PD; Lin RS
    Am J Infect Control; 2001 Feb; 29(1):41-7. PubMed ID: 11172317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends of drug resistant Mycobacterium tuberculosis in a tertiary tuberculosis center in Iran.
    Mirsaeidi MS; Tabarsi P; Farnia P; Ebrahimi G; Morris MW; Masjedi MR; Velayati AA; Mansouri D
    Saudi Med J; 2007 Apr; 28(4):544-50. PubMed ID: 17457475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emergence of drug-resistant tuberculosis in New York City.
    Frieden TR; Sterling T; Pablos-Mendez A; Kilburn JO; Cauthen GM; Dooley SW
    N Engl J Med; 1993 Feb; 328(8):521-6. PubMed ID: 8381207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Resistance and multiresistance to antitubercular drugs in Argentina and in other Latin American countries].
    de Kantor IN; Latini O; Barrera L
    Medicina (B Aires); 1998; 58(2):202-8. PubMed ID: 9706257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Initial drug resistance as a threat for tuberculosis control: the case of Buenaventura, Colombia].
    Moreira CA; Hernández HL; Arias NL; Castaño MC; Ferro BE; Jaramillos E
    Biomedica; 2004 Jun; 24 Supp 1():73-9. PubMed ID: 15495574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.